SCHEMBL15079193

SCHEMBL15079193

N#Cc1nc2c3ccc4c(=O)n5c(C#N)c(C#N)nc5c5ccc(c(=O)n2c1C#N)c3c45

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
BCL2 P10415 1/20 0.35
KMT2A Q03164 5/20 0.34
MEN1 O00255 4/20 0.34
MAPT P10636 3/20 0.34
CYP1A2 P05177 2/20 0.34
CAMKK1 Q8N5S9 2/20 0.34
CAMKK2 Q96RR4 2/20 0.34
MAPK1 P28482 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP7 P55210 1/20 0.34
AHR P35869 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13286477 1.00 KDM4E (0.37) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL13286469 0.92 KMT2A (0.33) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL13260822 0.86 KDM4E (0.30) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL23312308 0.85 KDM4E (0.32) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL13286445 0.83 KDM4E (0.41) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL13286449 0.83 KDM4E (0.41) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL14241807 0.83 BCAT1 (0.39) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL15077803 0.83 AHR (0.44) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL31513529 0.83 BCAT1 (0.39) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL15077800 0.82 ALDH1A1 (0.35) KDM4EALDH1A1GAAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130161591-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130161591-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT L1CAM, ETV6, ELAVL1 KDM4E 2506/4885ALDH1A1 1265/4885GAA 1280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.